Microcoat now offering Assay Development and Sample Measurement on MSD® Platform
Microcoat expands its technological portfolio by Meso Scale Discovery´s Electrochemiluminescence (MSD-ECL) platform. Based on non-radioactive electrochemiluminescent labels for ultra-sensitive detection, MSD yields higher sensitivity and broader dynamic range compared to ELISA technology. Microcoat offers development of assays from the scratch as well as transfer of classical ELISA formats in addition to method comparison, validation and sample measurement. Customers profit from our year-long experience in custom-fit optimization and manufacturing of antibody conjugates including MSD´s SULFO-Tag®.
MORE NEWS
- 23Mrz
Microcoat ist dabei! Ausbildungskampagne #Könnenlernen
Read More → - 09Mrz
Microcoat announces the 8th Monocyte-Activation Test Proficiency Test Program
Read More → - 09Feb
Der Abschlussjahrgang des Ausbildungsberufes „Agrartechnischer Assistent“ aus Landsberg besucht die Firma „Microcoat“
Read More → - 09Feb
Monocyte Activation Test (MAT) Munich/Bernried, GERMANY
Read More → - 09Feb
Low Endotoxin Recovery/Masking Training Course Munich/Bernried, GERMANY
Read More → - 19Dez
Merry Christmas!
Read More → - 15Dez
MAT-Santa has an early Christmas present for you!
Read More → - 03Nov
Microcoat announces the 7th Monocyte-Activation Test Proficiency Test Program
Read More → - 17Okt
Meet us at the PharmaLab 2022 Düsseldorf/Neuss, Germany
Read More → - 10Okt
Microcoat announces agreement with Olink to offer innovative proteomic approaches with Olink® Proximity Extension Assay (PEA) technology for pharma partners
Read More →
